Japan launches world's first viral drug for esophageal cancer
Japan begins commercial sales of the first viral therapy for esophageal cancer, developed by Oncolys BioPharma, using genetically modified viruses.
We haven't written up this one. Ajel English has the full story — the link below goes straight to it.